The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer
about
Is there a growing role for endocrine therapy in the treatment of breast cancer?Pharmacology and clinical experience with exemestane.FACE: the barefaced facts of AI potency.The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumDifferences between the non-steroidal aromatase inhibitors anastrozole and letrozole--of clinical importance?Aromatase inhibition in the treatment of advanced breast cancer: is there a relationship between potency and clinical efficacy?Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.Aromatase inhibitors and their future role in post-menopausal women with early breast cancer.Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancerAromatase inhibition 2013: clinical state of the art and questions that remain to be solvedAromatase inhibitors and other novel agents in breast cancer treatment.Aromatase inhibition for breast cancer treatment.Endocrine treatment of advanced breast cancer.Aromatase inhibitors: from bench to bedside and back.Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer.
P2860
Q33993658-01BA4681-C73E-495A-8F6E-0D8E6354BE6CQ34075034-D0DFBE5C-94AB-4A04-BE78-7F317B35D3CDQ34417834-8F46BAE7-3C77-42C3-8C37-951A26A0A2AAQ34592879-01B1A0CF-5E16-4E26-BBA9-2A12E2B54E3AQ34745884-45A14C58-169A-483A-A5E3-60779975A34BQ35776951-7DBA1648-73AB-4809-9784-3B3EDA959DE5Q35977200-F89F6ED9-B412-4999-A4FE-555A960D1E19Q35979241-E15FAED2-C62F-493B-89CB-1E6B3C4F5DEFQ36114457-3C3E17F5-9F03-4891-BD11-EA162628C32AQ36135060-912D3191-EF96-4065-8E7A-5F713F9C8022Q36138879-E86FFDF3-AD56-4372-83D0-32DA3EE3D669Q36432163-C911553D-373F-47C3-AFA1-49DB1E8696F8Q36946008-4AE9B0E3-3AAE-453A-80CA-966623852711Q40409345-2CB506C0-0F52-4F1A-A88B-5C998D202B79Q41463872-1D090B63-4997-4B1C-BFDC-1E2C9E8270F9Q41463923-1A9FFE28-5DFA-4B31-A9F9-E271A809B7FBQ46788411-9D457316-5C61-4A19-A72F-548BA58F81CAQ54076369-CE2D644A-6810-4BB4-AC43-80D3E5BEF8F4
P2860
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
The influence of aminoglutethi ...... aromatisation in breast cancer
@ast
The influence of aminoglutethi ...... aromatisation in breast cancer
@en
The influence of aminoglutethi ...... aromatisation in breast cancer
@nl
type
label
The influence of aminoglutethi ...... aromatisation in breast cancer
@ast
The influence of aminoglutethi ...... aromatisation in breast cancer
@en
The influence of aminoglutethi ...... aromatisation in breast cancer
@nl
prefLabel
The influence of aminoglutethi ...... aromatisation in breast cancer
@ast
The influence of aminoglutethi ...... aromatisation in breast cancer
@en
The influence of aminoglutethi ...... aromatisation in breast cancer
@nl
P2093
P2860
P356
P1476
The influence of aminoglutethi ...... aromatisation in breast cancer
@en
P2093
P2860
P2888
P356
10.1038/BJC.1992.339
P407
P577
1992-10-01T00:00:00Z
P5875
P6179
1027777001